VistaGen Therapeutics, Inc.VTGNNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
-27.7%/yr
vs +42.5%/yr prior
Acceleration
-70.2pp
Decelerating
Percentile
P62
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 16.67% |
| Q3 2025 | -14.89% |
| Q2 2025 | -6.82% |
| Q1 2025 | 4.35% |
| Q4 2024 | -9.52% |
| Q3 2024 | -20.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 18.60% |
| Q4 2023 | 34.85% |
| Q3 2023 | 29.79% |
| Q2 2023 | 45.03% |
| Q1 2023 | -20.42% |
| Q4 2022 | 44.09% |
| Q3 2022 | 11.50% |
| Q2 2022 | -18.11% |
| Q1 2022 | -55.77% |
| Q4 2021 | 21.61% |
| Q3 2021 | -63.11% |
| Q2 2021 | 5.43% |
| Q1 2021 | 34.18% |
| Q4 2020 | -33.33% |
| Q3 2020 | 19.67% |
| Q2 2020 | 12.02% |
| Q1 2020 | 49.76% |
| Q4 2019 | -10.11% |
| Q3 2019 | 13.96% |
| Q2 2019 | 11.00% |
| Q1 2019 | 30.35% |
| Q4 2018 | 18.40% |
| Q3 2018 | -57.09% |
| Q2 2018 | -2.04% |
| Q1 2018 | 16.95% |
| Q4 2017 | 57.16% |
| Q3 2017 | -101.46% |
| Q2 2017 | 15.60% |
| Q1 2017 | 5.61% |
| Q4 2016 | 18.41% |
| Q3 2016 | 0.09% |
| Q2 2016 | 90.37% |
| Q1 2016 | -229.70% |